Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Does Imatinib Mesylate Therapy Cause Growth Hormone Deficiency
Medical Principles and Practice, 08/05/09
Kebapcilar L et al. – The data showed that a large number of patients on imatinib mesylate therapy had GH deficiency. A study involving a larger number of patients with a matched control group is needed to confirm the present observations.
Related Articles
Depressive tendency in children with growth hormone deficiency
Journal of Paediatrics and Child Health, 10/23/09
Relevance Score: 71%
Endocrine Regulation of Feto-Placental Growth
Hormone Research, 10/27/09
Relevance Score: 69%
Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement
Metabolism-Clinical and Experimental, 10/26/09
Relevance Score: 69%
Placental growth hormone and growth hormone binding protein are first trimester maternal serum markers of Down syndrome
Prenatal Diagnosis, 10/22/09
Relevance Score: 69%
Growth hormone and protein metabolism
Clinical Nutrition, 11/17/09
Relevance Score: 68%
Today in Metabolism and Growth...keeping you current
Receive free subspecialty "5-minute updates" via email
Is Diabetic Ketoacidosis at Disease Onset a Result of Missed Diagnosis
The Journal of Pediatrics, 12/08/09
Metabolic Risk Profiles and Associated Risk Factors Among Vietnamese Adults in Ho Chi Minh City
Metabolic Syndrome and Related Disorders, 12/03/09
Prediction of Adult Height Based on Automated Determination of Bone Age
Journal of Clinical Endocrinology and Metabolism, 11/25/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease
Pituitary, 12/08/09
Pioglitazone and mechanisms of CV protection
QJM: An International Journal of Medicine, 12/08/09
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/07/09
Sponsor
Article Search
Sponsor


See Latest Articles


